Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
Alder House Alder Court St.Asaph Business Park
St.Asaph
LL17 OJL
UK
Contact person: Ian Jones
Telephone: +44 1745366813
E-mail: ian.r.jones@wales.nhs.uk
NUTS: UK
Internet address(es)
Main address: http://nwssp.nhs.wales/ourservices/procurement-services/
Address of the buyer profile: https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221
I.4) Type of the contracting authority
Regional or local authority
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
iLab Telepath Support and Disaster Recovery
II.1.2) Main CPV code
50324100
II.1.3) Type of contract
Services
II.1.4) Short description
Dedalus are the current incumbent supplier for Telepath, and the system hosts a vast archive of historical data which is used to assess cross matching compatibility. Transfusion throughout Wales has not moved to the national system (WLIMS) but is scheduled to do so under the new LINC arrangements. This is anticipated to commence 2024 in BCUHB subject to suitable verification and validation of performance, and hence a full cover period is required from 2021-2025. Therefore the only viable option is to retain the existing services and vital cover via a direct award process for service continuity, in order to ensure patient safety and ability to handle blood products in accordance with legislative requirements and national guidelines. Failure to award to the incumbent supplier will result in cessation of transfusion services with an impact to AE, Theatres, Maternity, cancer services and critical care services.
II.1.6) Information about lots
This contract is divided into lots:
No
II.2) Description
II.2.2) Additional CPV code(s)
48180000
II.2.3) Place of performance
NUTS code:
UKL
UKL2
UKL12
UKL13
Main site or place of performance:
Wrexham Maelor Hospital, Glan Clwyd Hospital,Ysbyty Gwynedd Bangor
II.2.4) Description of the procurement
The proposed contract with Dedalus for ilab Telepath support and disaster recovery is to ensure the service continuity for critical Transfusion delivery. Dedalus are the current incumbent supplier for Telepath, and the system hosts a vast archive of historical data which is used to assess cross matching compatibility. Transfusion throughout Wales has not moved to the national system (WLIMS) but is scheduled to do so under the new LINC arrangements. This is anticipated to commence 2024 in BCUHB subject to suitable verification and validation of performance, and hence a full cover period is required from 2021-2025. Therefore the only viable option is to retain the existing services and vital cover via a direct award process for service continuity, in order to ensure patient safety and ability to handle blood products in accordance with legislative requirements and national guidelines. Failure to award to the incumbent supplier will result in cessation of transfusion services with an impact to AE, Theatres, Maternity, cancer services and critical care services.
II.2.5) Award criteria
Quality criterion: as per procurement docs
/ Weighting: 100
Price
/ Weighting:
0
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Award of a contract without prior publication of a call for competition
Justification for selected award procedure:
The procurement falls outside the scope of application of the Directive
Explanation
The proposed contract with Dedalus for ilab Telepath support and disaster recovery is to ensure the service continuity for critical Transfusion delivery. Dedalus are the current incumbent supplier for Telepath, and the system hosts a vast archive of historical data which is used to assess cross matching compatibility. Transfusion throughout Wales has not moved to the national system (WLIMS) but is scheduled to do so under the new LINC arrangements. This is anticipated to commence 2024 in BCUHB subject to suitable verification and validation of performance, and hence a full cover period is required from 2021-2025. Therefore the only viable option is to retain the existing services and vital cover via a direct award process for service continuity, in order to ensure patient safety and ability to handle blood products in accordance with legislative requirements and national guidelines. Failure to award to the incumbent supplier will result in cessation of transfusion services with an impact to AE, Theatres, Maternity, cancer services and critical care services.
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
No
IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure
Notice number in the OJ S:
2021/S 000-028796
Section V: Award of contract
Contract No: N/a
A contract/lot is awarded:
No
V.1 Information on non-award
The contract/lot is not awarded
Other reasons (discontinuation of procedure)
Section VI: Complementary information
VI.3) Additional information
(WA Ref:123992)
VI.4) Procedures for review
VI.4.1) Review body
High Court
Royal Courts of Justice, The Strand
London
WC2A 2LL
UK
Telephone: +44 2079477501
VI.5) Date of dispatch of this notice
12/08/2022